Hosted on MSN15d
WuXi Biologics to sell Ireland-based vaccine site to MSD for $500m
WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025, the deal ...
China's WuXi Biologics to sell Ireland vaccine facility to Merck for $500 million
China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to Merck for about $500 million. WuXi had previously said it was planning to sell some of its operations as the ...
WuXi Biologics: Spotlight On Property Disposal And Operating Metrics (Rating Upgrade)
WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...
“Nothing to do with geopolitics”: WuXi Biologics CEO bullish in face of Biosecure
At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...
Wuxi Biologics Sells Vaccines Ireland Facility for $500M
Wuxi Biologics (Cayman) ( (HK:2269) ) has provided an announcement.
pharmaphorum1d
MSD buys Irish vaccines plant from WuXi for €500m
MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...
FiercePharma17d
In €500M deal, Merck buys Ireland vaccines plant from CDMO WuXi Biologics
In Ireland, WuXi Biologics has sold a new vaccine plant to Merck & Co. for €500 million ($521 million). The New Jersey company was a natural buyer of the facility as it was the lone client WuXi ...
Reuters17d
China's WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom
Jan 6 (Reuters) - China's WuXi Biologics (2269.HK), opens new tab said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co (MRK.N), opens new tab for about $500 ...
WuXi Biologics: Buy Rating Supported by Strong Performance, Strategic Growth, and Increased Target Price
CMB International Securities analyst Jill Wu has maintained their bullish stance on WXIBF stock, giving a Buy rating on January 13.Stay Ahead ...
Yahoo Finance16d
WuXi Biologics to sell Ireland-based vaccine site to MSD for $500m
WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...
Wall Street Journal16d
WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million
WuXi 2269-1.25%decrease; red down pointing triangle Biologics agreed to sell an overseas ... will sell its vaccine factory in Dundalk, Ireland, to U.S.-based Merck for about $500 million, it ...
Bloomberg L.P.16d
WuXi Bio to Sell Vaccine Facility to Merck for $500 Million
WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese company seeks to enhance its margins while continuing to navigate ...